Organisation paid for research Program year 2023 Source: CMS Open Payments

Wvu Clinical Research Unit

Neither a doctor nor a teaching hospital

Research payments

$35,178

6 payments

Through program year 2023, Wvu Clinical Research Unit is reported as receiving $35,178 in research payments, across 6 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2023	Research	$2,000	1
2022	Research	$28,778	3
2021	Research	$3,400	1
2019	Research	$1,000	1

Breakdown

Who paid Research payments · program years 2019–2023

AstraZeneca Pharmaceuticals LP $33,178 5 payments
AstraZeneca UK Limited $2,000 1 payment

Studies the money was for Research payments · program years 2019–2023

SERENA 4 A Randomised Multicentre Double Blind Phase 3 Study of AZD9833 (an Oral SERD) plus Palbociclib versus Anastrazole plus Palbociclib for the Treatment of Patients with Estrogen Receptor Positive HER2 Negative Advanced Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease $15,268 1 payment
A Dose-Escalating Study in Children With Hyperkalaemia Between Birth and less than 18 Years of Age to Evaluate Increasing Doses of Sodium Zirconium Cyclosilicate (SZC) Given Three Times Daily for the Correction of Hyperkalaemia and the Effectiveness of the Same Dose of SZC Given Once Daily to Maintain Normokalaemia Among Those Requiring Continuous Treatment $13,510 2 payments
A Phase 2 Open-label, Multicenter, Randomized, Multidrug Platform Study of Durvalumab (MEDI4736) Alone or in Combination with Novel Agents in Subjects with Locally Advanced, Unresectable, Stage III Non-small Cell Lung Cancer (COAST) $3,400 1 payment
Multicentre,Randomised,Double blind,Parallel Group,Placebo controlled,Time to first Asthma Exacerbation Phase tree Efficacy and Safety Study of Benralizumab in Paediatric Patients with Severe Eosinophilic Asthma Dominika $2,000 1 payment
Treatment Patterns Outcomes and Patient Reported Quality of Life A Prospective Disease Registry of Patients with Mantle Cell Lymphoma Treated with Novel Agents $1,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.